AU7540487A - Peptides involved in the pathogenesis of hiv infection - Google Patents
Peptides involved in the pathogenesis of hiv infectionInfo
- Publication number
- AU7540487A AU7540487A AU75404/87A AU7540487A AU7540487A AU 7540487 A AU7540487 A AU 7540487A AU 75404/87 A AU75404/87 A AU 75404/87A AU 7540487 A AU7540487 A AU 7540487A AU 7540487 A AU7540487 A AU 7540487A
- Authority
- AU
- Australia
- Prior art keywords
- pathogenesis
- hiv infection
- peptides involved
- peptides
- involved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000031886 HIV Infections Diseases 0.000 title 1
- 208000037357 HIV infectious disease Diseases 0.000 title 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 title 1
- 230000008506 pathogenesis Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87362186A | 1986-06-12 | 1986-06-12 | |
US873621 | 1986-06-12 | ||
US4193687A | 1987-04-24 | 1987-04-24 | |
US041936 | 1987-04-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7540487A true AU7540487A (en) | 1988-01-11 |
AU617088B2 AU617088B2 (en) | 1991-11-21 |
Family
ID=26718709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU75404/87A Ceased AU617088B2 (en) | 1986-06-12 | 1987-06-09 | Peptides involved in the pathogenesis of hiv infection |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0269712A4 (en) |
JP (1) | JPH01501547A (en) |
AU (1) | AU617088B2 (en) |
NZ (1) | NZ220653A (en) |
WO (1) | WO1987007616A1 (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5126399A (en) * | 1986-04-30 | 1992-06-30 | Board Of Regents, The University Of Texas System | Methods and compositions for the preparation and use of site-directed immunologic reagents |
EP0255190A3 (en) * | 1986-08-01 | 1990-08-29 | Repligen Corporation | Recombinant polypeptides and their uses, inclusing assay for aids virus |
US5166050A (en) * | 1986-08-20 | 1992-11-24 | Bristol-Myers Squibb Company | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections |
US5976541A (en) * | 1988-01-26 | 1999-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope |
NO881151L (en) * | 1987-03-27 | 1988-09-28 | Syntello Ab | SYNTHETIC HIV-1 ANTIGEN. |
FI872409A0 (en) * | 1987-05-29 | 1987-05-29 | Labsystems Oy | FOERFARANDE FOER DETEKTERING AV HIV-1 MOTKROPPAR. |
US5820865A (en) * | 1988-01-26 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides |
JP2569185B2 (en) * | 1988-01-26 | 1997-01-08 | アメリカ合衆国 | Synthetic antigen eliciting anti-HIV response |
US5763160A (en) * | 1988-02-12 | 1998-06-09 | United Biomedical, Inc. | Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines |
CA1341285C (en) * | 1988-02-12 | 2001-08-14 | Chang Yi Wang | Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
EP0339504A3 (en) * | 1988-04-26 | 1990-09-12 | The Du Pont Merck Pharmaceutical Company | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
US5562905A (en) * | 1988-04-26 | 1996-10-08 | E. I. Du Pont De Nemours And Company | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
KR900701836A (en) * | 1988-10-03 | 1990-12-04 | 라메쉬 엘. 라탄 | Peptides useful for diagnosing, preventing or treating new HIV proteins and AIDS |
US6309880B1 (en) * | 1989-04-25 | 2001-10-30 | Tanox, Inc. | Antibodies specific for CD4-binding domain of HIV-1 |
JPH0768276B2 (en) * | 1989-04-25 | 1995-07-26 | タノックス バイオシステムズ インコーポレイテッド | Antibodies specific for the CD4 binding region of HIV |
GB8912496D0 (en) * | 1989-05-31 | 1989-07-19 | Medical Res Council | Vaccines |
US5346989A (en) * | 1990-08-22 | 1994-09-13 | Syntello Vaccine Development Kb | Peptides for use in induction of T cell activation against HIV-1 |
US5840313A (en) * | 1990-09-27 | 1998-11-24 | Syntello Vaccine Development Kb | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
AU650911B2 (en) * | 1990-09-27 | 1994-07-07 | Syntello Vaccine Development Kb | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
EP0594638A1 (en) * | 1991-06-03 | 1994-05-04 | Syntello Vaccine Development Ab | Peptides for use in induction of t cell activation against hiv-1 |
US5444044A (en) * | 1992-03-26 | 1995-08-22 | New York Blood Center | Synthetic polypeptides as inhibitors of HIV-1 |
DE69311764T2 (en) * | 1992-05-14 | 1998-02-05 | Polymun Scient Immunbio Forsch | Peptides that induce antibodies that neutralize genetically divergent HIV-1 isolations |
NZ255256A (en) * | 1992-08-27 | 1997-02-24 | Deakin Res Ltd | Synthetic peptide antigen analogues with retro, inverso or retro-inverso modification, their use and antibodies against them |
US5464933A (en) * | 1993-06-07 | 1995-11-07 | Duke University | Synthetic peptide inhibitors of HIV transmission |
DE4405810A1 (en) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Peptides derived from a retrovirus from the HIV group and their use |
FR2717081B1 (en) * | 1994-03-14 | 1996-06-21 | Centre Nat Rech Scient | Retropeptides, antibodies to the latter, and their uses for vaccination and in vitro diagnosis. |
EP0868196A4 (en) * | 1995-10-20 | 2004-11-24 | Univ Duke | Synthetic vaccine for protection against human immunodeficiency virus infection |
US6749856B1 (en) | 1997-09-11 | 2004-06-15 | The United States Of America, As Represented By The Department Of Health And Human Services | Mucosal cytotoxic T lymphocyte responses |
DK1071442T3 (en) * | 1998-03-23 | 2005-10-24 | Trimeris Inc | Methods and Preparations for Peptide Synthesis (T-20) |
US6281331B1 (en) * | 1998-03-23 | 2001-08-28 | Trimeris, Inc. | Methods and compositions for peptide synthesis |
ES2366185T3 (en) * | 2003-04-11 | 2011-10-18 | Institut Pasteur | SYNTHETIC PEPTIDES VACCINES FOR HIV: THE EPDOPE OF CBD AS AN EFFECTIVE IMMUNOGEN TO PROVIDE WIDE NEUTRALIZING ANTIBODIES AGAINST HIV. |
US20060205070A1 (en) * | 2004-01-13 | 2006-09-14 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | HIV TEV compositions and methods of use |
EP1714153A2 (en) * | 2004-02-06 | 2006-10-25 | I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale | A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual |
WO2007039458A2 (en) * | 2005-09-21 | 2007-04-12 | Cytos Biotechnology Ag | Hiv peptide conjugates and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES8705522A1 (en) * | 1984-10-18 | 1987-05-01 | Pasteur Institut | Gag antigen and its use for the detection of lav infection and in immunogenic compositions |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
GB8525615D0 (en) * | 1985-10-17 | 1985-11-20 | Hoffmann La Roche | Polypeptides |
US4772547A (en) * | 1986-02-03 | 1988-09-20 | Hoffmann-La Roche Inc. | HTLV-III envelope peptides |
-
1987
- 1987-06-09 WO PCT/US1987/001294 patent/WO1987007616A1/en not_active Application Discontinuation
- 1987-06-09 AU AU75404/87A patent/AU617088B2/en not_active Ceased
- 1987-06-09 JP JP62503612A patent/JPH01501547A/en active Pending
- 1987-06-09 EP EP19870903968 patent/EP0269712A4/en not_active Withdrawn
- 1987-06-11 NZ NZ220653A patent/NZ220653A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ220653A (en) | 1990-06-26 |
WO1987007616A1 (en) | 1987-12-17 |
EP0269712A4 (en) | 1990-06-26 |
JPH01501547A (en) | 1989-06-01 |
AU617088B2 (en) | 1991-11-21 |
EP0269712A1 (en) | 1988-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU617088B2 (en) | Peptides involved in the pathogenesis of hiv infection | |
AU588672B2 (en) | Ceramics | |
AU7956487A (en) | Peptide derivatives | |
AU585812B2 (en) | Divergent single filer | |
AU7668187A (en) | N-phenylbutenamides with pharmaceutical properties | |
AU2157888A (en) | Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids | |
AU1382488A (en) | Cyclic peptides and their preparation | |
AU7851687A (en) | Anti-inflammatory peptides | |
AU5449590A (en) | Anti-hiv drug | |
AU7635887A (en) | Recombinant HTLV-III proteins and uses thereof | |
AU573472B2 (en) | Button | |
AU2937489A (en) | Anti-hiv agent | |
AU604793B2 (en) | Env/gag-polypeptides | |
AU7395987A (en) | Vaccine | |
AU600015B2 (en) | Stacker | |
AU7713387A (en) | Hepatitis vaccine | |
AU7993087A (en) | Protein purification | |
AU7984487A (en) | Pharmaceutical combination | |
AU7843287A (en) | Novel preparation | |
AU8129987A (en) | Pyrrolo-benzimidazoles, their preparation and use | |
AU7044387A (en) | Molluscicides | |
AU1676288A (en) | Human immunodeficiency virus gag-encoded proteins | |
AU8268887A (en) | Aminoethylisoxazolidines, their preparation and use | |
AU6516186A (en) | Garment | |
AU588421B2 (en) | Structures |